Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus (HIV) Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05832502
What this trial is testing

Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)

Who this might be right for
Group B Streptococcal Infection
St George's, University of London 300
Not applicableEnded earlyNCT01904201
What this trial is testing

Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People

Who this might be right for
HIV Positive
QIAGEN Gaithersburg, Inc 57
Testing effectiveness (Phase 2)Study completedNCT05064956
What this trial is testing

Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)

Who this might be right for
Ebola Virus DiseaseEbolaHiv
London School of Hygiene and Tropical Medicine 26
Early research (Phase 1)Study completedNCT00000721
What this trial is testing

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Not applicableActive Not RecruitingNCT05220163
What this trial is testing

Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19

Who this might be right for
TuberculosisCOVID-19HIV Infections
University of Cape Town 26,200
Large-scale testing (Phase 3)Study completedNCT06403787
What this trial is testing

Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment

Who this might be right for
Human Immunodeficiency Virus
University of Guadalajara 28
Large-scale testing (Phase 3)Study completedNCT02537236
What this trial is testing

Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.

Who this might be right for
Human Immunodeficiency Virus
Instituto Mexicano del Seguro Social 200
Testing effectiveness (Phase 2)Ended earlyNCT00858793
What this trial is testing

High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT

Who this might be right for
AIDS-related LymphomaHIV Infections
Universitätsklinikum Hamburg-Eppendorf 5
Post-approval studies (Phase 4)Looking for participantsNCT06762730
What this trial is testing

Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals

Who this might be right for
HIV Infected IndividualsOsteopenia
Hadassah Medical Organization 110
Post-approval studies (Phase 4)Study completedNCT01599364
What this trial is testing

Atazanavir/r + Lamivudine Dual Therapy

Who this might be right for
Human Immunodeficiency Virus
Catholic University of the Sacred Heart 266
Testing effectiveness (Phase 2)Ended earlyNCT00286377
What this trial is testing

Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients

Who this might be right for
HIVPeripheral Nervous System Disorders
Savient Pharmaceuticals 350
Early research (Phase 1)Study completedNCT00000857
What this trial is testing

Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 65
Testing effectiveness (Phase 2)Study completedNCT02237365
What this trial is testing

A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis

Who this might be right for
Tuberculous Meningitis
Oxford University Clinical Research Unit, Vietnam 120
Early research (Phase 1)Study completedNCT00412477
What this trial is testing

A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05122026
What this trial is testing

Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV

Who this might be right for
HIV SeropositivityPregnancyTuberculosis Infection
The Aurum Institute NPC 252
Not applicableStudy completedNCT03762187
What this trial is testing

A Brief Affirmation Intervention on HIV-related Distress and Positive Living in Lesotho

Who this might be right for
Self-affirmation Plus Positive Living CounselingCounseling
University of California, Santa Barbara 389
Not applicableStudy completedNCT00762320
What this trial is testing

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Who this might be right for
HIV Infections
Phoenix Children's Hospital 8
Not applicableStudy completedNCT00661960
What this trial is testing

Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy

Who this might be right for
HIV InfectionsAIDS
University of California, Davis 25
Post-approval studies (Phase 4)Study completedNCT04166474
What this trial is testing

Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

Who this might be right for
HivTuberculosis
Helen Reynolds 36
Testing effectiveness (Phase 2)Study completedNCT00017810
What this trial is testing

The Healthy Life Choices Project in HIV-Positive Patients

Who this might be right for
DiarrheaHIV Infections
Columbia University 75
Next Page